SG/CALL/NOVO-NORDISK B/1100/0.1/19.06.26 Stock

Warrant

DE000SU9CV56

Market Closed - Boerse Frankfurt Warrants 15:44:19 2024-05-31 EDT
2.12 EUR +1.92% Intraday chart for SG/CALL/NOVO-NORDISK B/1100/0.1/19.06.26
1 month-6.22%
3 months+20.57%
Date Price Change
24-05-31 2.11 +1.44%
24-05-30 2.08 -0.95%
24-05-29 2.1 -2.78%
24-05-28 2.16 -3.57%
24-05-27 2.24 -3.45%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 03:44 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU9CV5
ISINDE000SU9CV56
Date issued 2024-02-14
Strike 1,100 kr
Maturity 2026-06-19 (747 Days)
Parity 10 : 1
Emission price 1.75
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.57
Lowest since issue 1.68
Delta0x
Omega 0.000000
Premium0x
Gearing5.68x
Moneyness 0.8430
Difference Strike 172.7 kr
Difference Strike %+15.70%
Spread 0.03
Spread %1.36%
Intrinsic value 0.000000
Present value 2.175

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus